Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Devang Mehta of Anand Rathi Financial Services is of the view that CARE may test Rs 2100-2200.
Manav Chopra of Nirmal Bang is of the view that one may buy Credit Analysis and Research with a target of Rs 1520 and buy Hindustan Zinc with a target of Rs 172.
Manas Jaiswal of manasjaiswal.com advises buying Bank of India with a target of Rs 265 and NMDC with a target of Rs 144.
Meghana V Malkan of malkansview.com advises buying Crompton Greaves with a target of Rs 235-242 and India Cements with a target of Rs 126-132.
Rajesh Kothari, Managing Director at AlfAccurate Advisors has a bullish stance on Credit Analysis and Research.
Nitin Raheja, founder of ADF Advisors likes KPIT Technologies and Tech Mahindra within the midcap IT space. He also likes rating agency CARE.
According to SP Tulsian of sptulsian.com, one can expect a price of Rs 900 in next six months on CARE. It is the second largest rating company.
SP Tulsian is bullish on CARE Ratings and JK Cement. He expects both these stocks to fetch high returns in future.
Credit Analysis and Research (CARE) can move to about Rs 1150 in the next 8-10 months, says SP Tulsian of sptulsian.com.
Credit Analysis and Research (CARE) can move to Rs 1050-1100, says Ambareesh Baliga, Independent Analyst.